查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585657

生物製药第三方物流市场：按供应链、服务类型划分 - 全球预测 2025-2030

Biopharmaceutical Third Party Logistics Market by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing & Storage) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生医第三方物流市场规模为1,070.8亿美元，预估2024年将达1,217.7亿美元，复合年增长率为14.20%，2030年将达2,713.2亿美元，预估将达1,000万美元。

生物製药第三方物流（3PL）市场在生物製药的高效管理和分销中发挥关键作用，包括针对温度和时间敏感的药品量身定制的仓储、运输和物流技术，提供端到端服务。全球药品供应链日益复杂，并且需要遵守严格的监管标准，同时确保安全且有效率地交付高价值生技药品，这推动了对这些服务的需求。应用涵盖医院、专科诊所和药房等各种最终用途领域，促进疫苗、单株抗体和其他生物製药的分销。该市场的成长是由对特种药品的需求不断增长、物流技术的进步（例如用于即时监控的物联网和人工智慧）以及生物製药产能的扩大所推动的。新的商机在于区块链的整合，以提高供应链的透明度和安全性，随着产业寻求降低风险和提高合规性，这一点变得越来越有吸引力。然而，其限制包括由于需要专门的基础设施而导致营运成本较高，以及不同地区不断变化的法规所带来的复杂性。此外，许多生物製药的利基性质需要单独的储存和运输解决方案，并且扩充性仍然是一个挑战。创新应着重于永续物流解决方案，旨在减少碳足迹，开发适应性低温运输解决方案，并加强预测物流规划的资料分析能力。该市场本质上是竞争性的，其特点是物流提供商和生物製药公司之间旨在优化其物流网络的战略联盟和合併。相关人员应优先投资技术主导的解决方案，以提高业务效率和服务差异化，同时专注于区域扩大策略，以开拓药品需求不断增长的新兴市场。

主要市场统计
基准年[2023] 1070.8亿美元
预测年份 [2024] 1217.7亿美元
预测年份 [2030] 2713.2亿美元
复合年增长率（%） 14.20%

市场动态：揭示快速发展的生物製药第三方物流市场的关键市场洞察

供需的动态交互作用正在改变生物製药第三方物流市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 製药和生物製药行业的研发 (R&D) 支出不断增加
    • 对运输生技药品的温控物流服务的需求不断增长
    • 各医疗机构外包物流上升趋势
  • 市场限制因素
    • 药物开发和药物发现程序的高成本
  • 市场机会
    • 生物製药第三方物流解决方案的技术进步不断进步
    • 对生物相似药的需求迅速增加
  • 市场挑战
    • 关于国际物流程序的严格政府规章制度

波特五力：驾驭生物製药第三方物流市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物製药第三方物流市场的外部影响

外部宏观环境因素对生物製药第三方物流市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物製药第三方物流市场竞争格局

对生物製药第三方物流市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 生物製药第三方物流市场中的定位矩阵供应商绩效评估

FPNV定位矩阵是评估生物製药第三方物流市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议描绘生物製药第三方物流市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物製药第三方物流市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医药及生技製药产业研发费用增加
      • 运送生技药品时对温控物流服务的需求不断增加
      • 各医疗机构物流外包新趋势
    • 抑制因素
      • 药物开发和药物发现程序的高成本
    • 机会
      • 扩大生物製药第三方物流解决方案的技术进步
      • 生物相似药需求快速成长
    • 任务
      • 关于国际物流程序的严格政府规章制度
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 生物医药第三方物流市场供应链

  • 低温运输
  • 非低温运输

第七章生物製药第三方物流市场：依服务类型

  • 运输
    • 空运
    • 陆上
    • 海运
  • 仓储

第八章美洲生物製药第三方物流市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物医药第三方物流市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲生物製药第三方物流市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agility Public Warehousing Company KSCP
  • AmerisourceBergen Corporation
  • CH Robinson Worldwide, Inc.
  • CEVA Logistics AG
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Hitachi Transport System, Ltd.
  • Kerry Logistics Network Ltd.
  • Kuehne+Nagel International AG
  • McKesson Corporation
  • Nippon Express Co., Ltd.
  • Schenker AG
  • Schneider National, Inc.
  • SF Express Co., Ltd.
  • United Parcel Service of America, Inc.
  • XPO Logistics, Inc.
Product Code: MRR-563BF1FCF7FA

The Biopharmaceutical Third Party Logistics Market was valued at USD 107.08 billion in 2023, expected to reach USD 121.77 billion in 2024, and is projected to grow at a CAGR of 14.20%, to USD 271.32 billion by 2030.

The biopharmaceutical third-party logistics (3PL) market plays a crucial role in efficiently managing and distributing biopharmaceutical products, providing end-to-end services including warehousing, transportation, and logistics technology tailored for temperature-sensitive and time-critical pharmaceuticals. The necessity of these services is driven by the increasing complexity of the global pharmaceutical supply chain and the need to adhere to stringent regulatory standards while ensuring the safe and efficient delivery of high-value biologics. Applications span across various end-use sectors including hospitals, specialized clinics, and pharmacies, facilitating the distribution of vaccines, monoclonal antibodies, and other biotech drugs. Growth in this market is being fueled by the rising demand for specialty medicines, advancements in logistics technology (like IoT and AI for real-time monitoring), and the expansion of biopharmaceutical production capacities. An emerging opportunity lies in the integration of blockchain for enhanced transparency and security in supply chains, which is increasingly appealing as the industry seeks to mitigate risk and improve compliance. However, the market faces limitations such as high operational costs due to the need for specialized infrastructure and the complexities associated with navigating constantly evolving regulations across different territories. Furthermore, scalability remains challenging due to the niche nature of many biopharmaceuticals requiring tailored storage and transport solutions. Innovation should focus on sustainable logistics solutions aimed at reducing carbon footprint, developing adaptive cold chain solutions, and enhancing data analytics capabilities for predictive logistics planning. The market is inherently competitive, characterized by strategic collaborations and mergers among logistics providers and biopharma companies seeking to optimize distribution networks. Stakeholders should prioritize investments in technology-driven solutions to improve operational efficiency and service differentiation, while also focusing on regional expansion strategies to tap into emerging markets with growing pharmaceutical needs.

KEY MARKET STATISTICS
Base Year [2023] USD 107.08 billion
Estimated Year [2024] USD 121.77 billion
Forecast Year [2030] USD 271.32 billion
CAGR (%) 14.20%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Third Party Logistics Market

The Biopharmaceutical Third Party Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
    • Rising need for temperature-controlled logistic services to transport biologics
    • Emerging trend of outsourcing logistics by various medical organizations
  • Market Restraints
    • High costs of drug development and drug discovery procedures
  • Market Opportunities
    • Growing technological advancements in biopharmaceutical third party logistics solutions
    • Rapidly growing need for the biosimilar medicines
  • Market Challenges
    • Stringent governmental rules and regulations for international logistics procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Third Party Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Third Party Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Third Party Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Third Party Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Third Party Logistics Market

A detailed market share analysis in the Biopharmaceutical Third Party Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Third Party Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Third Party Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Third Party Logistics Market

A strategic analysis of the Biopharmaceutical Third Party Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Third Party Logistics Market, highlighting leading vendors and their innovative profiles. These include Agility Public Warehousing Company K.S.C.P, AmerisourceBergen Corporation, C.H. Robinson Worldwide, Inc., CEVA Logistics AG, DB Schenker, DHL International GmbH, FedEx Corporation, Hitachi Transport System, Ltd., Kerry Logistics Network Ltd., Kuehne + Nagel International AG, McKesson Corporation, Nippon Express Co., Ltd., Schenker AG, Schneider National, Inc., SF Express Co., Ltd., United Parcel Service of America, Inc., and XPO Logistics, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Third Party Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Supply Chain, market is studied across Cold Chain and Non-Cold Chain.
  • Based on Service Type, market is studied across Transportation and Warehousing & Storage. The Transportation is further studied across Air Freight, Overland, and Sea Freight.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
      • 5.1.1.2. Rising need for temperature-controlled logistic services to transport biologics
      • 5.1.1.3. Emerging trend of outsourcing logistics by various medical organizations
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of drug development and drug discovery procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing technological advancements in biopharmaceutical third party logistics solutions
      • 5.1.3.2. Rapidly growing need for the biosimilar medicines
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental rules and regulations for international logistics procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Third Party Logistics Market, by Supply Chain

  • 6.1. Introduction
  • 6.2. Cold Chain
  • 6.3. Non-Cold Chain

7. Biopharmaceutical Third Party Logistics Market, by Service Type

  • 7.1. Introduction
  • 7.2. Transportation
    • 7.2.1. Air Freight
    • 7.2.2. Overland
    • 7.2.3. Sea Freight
  • 7.3. Warehousing & Storage

8. Americas Biopharmaceutical Third Party Logistics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Third Party Logistics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Third Party Logistics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agility Public Warehousing Company K.S.C.P
  • 2. AmerisourceBergen Corporation
  • 3. C.H. Robinson Worldwide, Inc.
  • 4. CEVA Logistics AG
  • 5. DB Schenker
  • 6. DHL International GmbH
  • 7. FedEx Corporation
  • 8. Hitachi Transport System, Ltd.
  • 9. Kerry Logistics Network Ltd.
  • 10. Kuehne + Nagel International AG
  • 11. McKesson Corporation
  • 12. Nippon Express Co., Ltd.
  • 13. Schenker AG
  • 14. Schneider National, Inc.
  • 15. SF Express Co., Ltd.
  • 16. United Parcel Service of America, Inc.
  • 17. XPO Logistics, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY NON-COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY OVERLAND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 144. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023